These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 7940945)
21. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation. Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219 [No Abstract] [Full Text] [Related]
22. Clinical impact of Neoral in thoracic organ transplantation. Aziz T; el-Gamel A; Keevil B; Krysiak P; Campbell C; Rahman A; Deiraniya A; Yonan N Transplant Proc; 1998 Aug; 30(5):1900-3. PubMed ID: 9723326 [No Abstract] [Full Text] [Related]
23. Circadian variations in the pharmacokinetics of a new microemulsion formulation of cyclosporine in cardiac transplant recipients. Châteauvert N; Côté H Pharmacotherapy; 1998; 18(2):364-70. PubMed ID: 9545156 [TBL] [Abstract][Full Text] [Related]
24. Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral. Serafinowicz A; Gaciong Z; Baçzkowska T; Rell K; Lao M; Wałaszewski J Transplant Proc; 1996 Dec; 28(6):3138-9. PubMed ID: 8962216 [No Abstract] [Full Text] [Related]
25. The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine. Holt DW; Mueller EA; Kovarik JM; van Bree JB; Kutz K Transplant Proc; 1994 Oct; 26(5):2935-9. PubMed ID: 7940927 [No Abstract] [Full Text] [Related]
26. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune. Pescovitz MD; Henson S; Bodziak K; Book BK; Gonin J; Jindal RM; Leapman SB; Milgrom ML; Filo RS Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189 [No Abstract] [Full Text] [Related]
27. Conversion from Sandimmune to Neoral in stable heart transplant recipients. Pethig K; Ruhparwar A; Korn A; Christians U; Wahlers T Transplant Proc; 1996 Aug; 28(4):2287-9. PubMed ID: 8769228 [No Abstract] [Full Text] [Related]
28. Follow-up after conversion to Neoral in stable heart transplant recipients. Pethig K; Geiger M; Korn A; Grote M; Christians U; Wahlers T Transplant Proc; 1996 Aug; 28(4):2282-4. PubMed ID: 8769226 [No Abstract] [Full Text] [Related]
29. Cyclosporine levels in diabetic (type 1) patients undergoing kidney and pancreas transplantation: role of a new galenica formulation. Storck M; Mickley V; Gräb C; Steinbach G; Abendroth D Transplant Proc; 1994 Oct; 26(5):2996-8. PubMed ID: 7940946 [No Abstract] [Full Text] [Related]
30. Sandimmun neoral, a new oral formulation of cyclosporin A with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients. Taesch S; Niese D; Mueller EA Transplant Proc; 1994 Dec; 26(6):3147-9. PubMed ID: 7998097 [No Abstract] [Full Text] [Related]
31. Assessment of cyclosporine pharmacokinetic parameters to facilitate conversion from C0 to C2 monitoring in heart transplant recipients. Davies RA; Veinot JP; Williams K; Haddad H; Baker A; Donaldson J; Pugliese C; Struthers C; Masters RG; Hendry PJ; Mesana T Transplant Proc; 2007 Dec; 39(10):3334-9. PubMed ID: 18089382 [TBL] [Abstract][Full Text] [Related]
32. Minor influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine. Mueller EA; Kovarik JM; Kutz K Transplant Proc; 1994 Oct; 26(5):2957-8. PubMed ID: 7940933 [No Abstract] [Full Text] [Related]
33. Proton magnetic resonance spectroscopy of blood plasma in heart transplant recipients treated with cyclosporine: an early prognosis test of long-term graft tolerance. Le Floch M; Ramee MP; LeLong B; Leray G; Kerbaol M; de Certaines JD J Heart Lung Transplant; 1997 Apr; 16(4):381-6. PubMed ID: 9154946 [TBL] [Abstract][Full Text] [Related]
34. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection? el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients. Cooney GF; Lum BL; Meligeni JA; Dunn SP Transplant Proc; 1996 Aug; 28(4):2270-2. PubMed ID: 8769222 [No Abstract] [Full Text] [Related]
37. Sole immunosuppressive maintenance with cyclosporine A after heart transplantation. Koerner MM; Tenderich G; Mannebach H; zu Knyphausen E; Koertke H; Kleesiek K; Gleichmann U; Meyer H; Koerfer R Transplant Proc; 1996 Dec; 28(6):3119-21. PubMed ID: 8962209 [No Abstract] [Full Text] [Related]
38. Cyclosporine neoral monitoring and its correlation with the "area under the curve". Sabbatiello R; Sgrosso JL; Schiavelli R; Castro C; Ahualli L; Pattin M; Vazquez MC Transplant Proc; 1996 Dec; 28(6):3378. PubMed ID: 8962317 [No Abstract] [Full Text] [Related]
39. Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients. Hartmann A; Andereassen AK; Holdaas H; Simonsen S; Geiran O; Berg KJ J Heart Lung Transplant; 1996 Oct; 15(10):972-9. PubMed ID: 8913913 [TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up after heart transplantation in Chagas' disease. Bocchi EA; Bellotti G; Uip D; Kalil J; de Lourdes Higuchi M; Fiorelli A; Stolf N; Jatene A; Pilleggi F Transplant Proc; 1993 Feb; 25(1 Pt 2):1329-30. PubMed ID: 8442131 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]